These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10878348)

  • 21. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.
    Colluru VT; McNeel DG
    Oncotarget; 2016 Oct; 7(42):67901-67918. PubMed ID: 27661128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity.
    Davila E; Celis E
    J Immunol; 2000 Jul; 165(1):539-47. PubMed ID: 10861094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
    Mitchell DA; Nair SK; Gilboa E
    Eur J Immunol; 1998 Jun; 28(6):1923-33. PubMed ID: 9645374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
    Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
    J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice.
    Spies B; Hochrein H; Vabulas M; Huster K; Busch DH; Schmitz F; Heit A; Wagner H
    J Immunol; 2003 Dec; 171(11):5908-12. PubMed ID: 14634101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A; Gilboa E
    J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells.
    Heit A; Maurer T; Hochrein H; Bauer S; Huster KM; Busch DH; Wagner H
    J Immunol; 2003 Mar; 170(6):2802-5. PubMed ID: 12626528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL.
    Luketic L; Delanghe J; Sobol PT; Yang P; Frotten E; Mossman KL; Gauldie J; Bramson J; Wan Y
    J Immunol; 2007 Oct; 179(8):5024-32. PubMed ID: 17911587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutting edge: cross-presentation of cell-associated antigens to MHC class I molecule is regulated by a major transcription factor for heat shock proteins.
    Zheng H; Li Z
    J Immunol; 2004 Nov; 173(10):5929-33. PubMed ID: 15528326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo.
    Harmala LA; Ingulli EG; Curtsinger JM; Lucido MM; Schmidt CS; Weigel BJ; Blazar BR; Mescher MF; Pennell CA
    J Immunol; 2002 Nov; 169(10):5622-9. PubMed ID: 12421941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells.
    Chattergoon MA; Robinson TM; Boyer JD; Weiner DB
    J Immunol; 1998 Jun; 160(12):5707-18. PubMed ID: 9637479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
    Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
    J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.
    Maurer T; Heit A; Hochrein H; Ampenberger F; O'Keeffe M; Bauer S; Lipford GB; Vabulas RM; Wagner H
    Eur J Immunol; 2002 Aug; 32(8):2356-64. PubMed ID: 12209649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncovalent association with stress protein facilitates cross-priming of CD8+ T cells to tumor cell antigens by dendritic cells.
    Kammerer R; Stober D; Riedl P; Oehninger C; Schirmbeck R; Reimann J
    J Immunol; 2002 Jan; 168(1):108-17. PubMed ID: 11751953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB; Eriksson K; Li BL; Lindblad M; Azem J; Holmgren J
    Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.
    Rice J; Elliott T; Buchan S; Stevenson FK
    J Immunol; 2001 Aug; 167(3):1558-65. PubMed ID: 11466377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
    Nelson D; Bundell C; Robinson B
    J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A; Snyder D; Gilboa E
    J Immunol; 1996 Apr; 156(8):2918-26. PubMed ID: 8609412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.